GCP
TFFP

GSA Capital Partners’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

GSA Capital Partners’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,747
Closed -$529K – 1940
2022
Q2 		$529K Sell
3,747
-469
-11% -$65.4K 0.08% 466
2022
Q1 		$665K Sell
4,216
-954
-18% -$154K 0.09% 371
2021
Q4 		$1.15M Sell
5,170
-642
-11% -$124K 0.14% 147
2021
Q3 		$1.12M Buy
5,812
+2,721
+88% +$578K 0.11% 256
2021
Q2 		$743K Buy
+3,091
New +$848K 0.08% 380

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

GSA Capital Partners's TFFP Position: Q3 2022 in Review

GSA Capital Partners sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2022, closing a stake of 3,747 shares — an estimated $529K sold.

GSA Capital Partners first reported a position in TFFP in Q2 2021 and held it in 5 quarters. The position peaked at $1.15M in Q4 2021. 45 funds tracked by Wall St. Rank hold TFFP as of Q3 2022.

  • GSA Capital Partners reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • GSA Capital Partners sold 3,747 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $529K.
  • GSA Capital Partners first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • GSA Capital Partners's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.15M in Q4 2021.
  • 45 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.